6505-13-120-4156
Clindamycin Palmitate Hydrochloride For Oral Suspension
6505131204156 131204156 DALACIN C SIR 80 ML - 75MG/5 ML 0030916 J01FF01
INC: 32003 Clindamycin Palmitate Hydrochloride For Oral Suspension
Managed by Belgium
NSN Created on 22 Aug 2008
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality

Marketplace 6505-13-120-4156
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-13-120-4156 5+ Documents (More...)
DALACIN C SIR 80 ML - 75MG/5 ML 0030916 J01FF01 Managed by Belgium NSN Created on 22 Aug 2008 Data Last
Changed January 2023 NATO Update Count 1 NATO Data Quality NSN 6505-13-120-4156 (Generic Image) 1/1
RQST NE Updated Every Day 6505-13-120-4156 RQST Updated Every Day 6505-13-120-4156 RQST NE Related Documents
Changed January 2023 NATO Update Count 1 NATO Data Quality NSN 6505-13-120-4156 (Generic Image) 1/1
RQST NE Updated Every Day 6505-13-120-4156 RQST Updated Every Day 6505-13-120-4156 RQST NE Related Documents
Hydrochloride For Oral Suspension6505430006176 430006176 DALACIN C DALACIN C 75 MG/5 ML GRANULAT 8- J01FF01
6505/pl 6505-43-000-61766505430006176430006176,DALACIN C SIR 80 ML - 75MG/5 ML 0030916 J01FF01 https
//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-120-4156 6505131204156 131204156 . 6505-13-120-4156Clindamycin
6505/pl 6505-43-000-61766505430006176430006176,DALACIN C SIR 80 ML - 75MG/5 ML 0030916 J01FF01 https
//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-120-4156 6505131204156 131204156 . 6505-13-120-4156Clindamycin
J01FF01 6505PL0155755 Managed by Poland NSN Created on 6 Jun 2011 Data Last Changed January 2023 NATO
6505131204156 131204156 Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR
80 ML - 75MG/5 ML 0030916 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2279 Clindamycin
6505131204156 131204156 Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR
80 ML - 75MG/5 ML 0030916 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2279 Clindamycin
2279Clindamycin Injecti6505430012279 430012279 CLINDO CLINDO 600 MG/4ML 5 AMP. 4 ML R- 5909990948314 J01FF01
6505131204156 131204156 Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR
80 ML - 75MG/5 ML 0030916 J01FF01 Clindamycin Injecti 6505430012279430012279J01FF01 6505PL0155755 Managed
6505131204156 131204156 Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR
80 ML - 75MG/5 ML 0030916 J01FF01 Clindamycin Injecti 6505430012279430012279J01FF01 6505PL0155755 Managed
6505131204156 131204156 Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR
80 ML - 75MG/5 ML 0030916 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2279 Clindamycin
Injecti 6505430012279 430012279 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2277 Clindamycin
80 ML - 75MG/5 ML 0030916 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2279 Clindamycin
Injecti 6505430012279 430012279 J01FF01 www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-2277 Clindamycin
Restrictions 6505-13-120-4156
End Users 6505-13-120-4156
- Belgium (ZB)
Approved Sources 6505-13-120-4156
- Part Number
- Manufacturer
- Status
- DALACIN C SIR 80 ML - 75MG/5 ML
- Manufacturer
- B0010 - Pfizer (Active)
- Primary Buy
- Primary Buy
- 0030916
- B6095 - Association Pharmaceutique (Active)
- Secondary Buy
- Secondary Buy
- J01FF01
- I9022 - Who Collaborating Centre For Drug (Active)
- Canceled/Obsolete
- Canceled/Obsolete
Similar Supply Items to 6505-13-120-4156

















